Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Neumora Therapeutics
Neumora Therapeutics
5 Life Sciences IPOs in 2023—and the Future Forecast
5 Life Sciences IPOs in 2023—and the Future Forecast
BioSpace
Neumora Therapeutics
RayzeBio
Adlai Nortye
Jyong Biotech
Metagenomi
Flag link:
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
BioSpace
biotech
IPOs
Neumora Therapeutics
Rome Therapeutics
Generate Biomedicines
Flag link:
RayzeBio, Neumora price some of biotech’s largest IPOs this year
RayzeBio, Neumora price some of biotech’s largest IPOs this year
BioPharma Dive
IPOs
RayzeBio
Neumora Therapeutics
Flag link:
Neumora, a richly funded brain drug developer, readies for an IPO
Neumora, a richly funded brain drug developer, readies for an IPO
BioPharma Dive
Neumora Therapeutics
IPOs
depression
navacaprant
Flag link:
Allied with Amgen and backed by $500M, Neumora brings data science to brain drugs
Allied with Amgen and backed by $500M, Neumora brings data science to brain drugs
MedCity News
Neumora Therapeutics
R&D
Amgen
funding
data science
drug development
Flag link:
